Localized modulation of tissues and cells to enhance therapeutic effects including renal denervation
AssigneeMercator MedSystems, Inc.
InventorKirk P. SEWARD
Life of this patent
Estimating the term…
Loading patent…
AssigneeMercator MedSystems, Inc.
InventorKirk P. SEWARD
Estimating the term…
Pharmaceutical preparations, compositions, systems, and devices including medical devices and diagnostic or therapeutic agents, and methods to treat disease by modification of local tissue environment to modulate the therapeutic index of locally or systemically delivered therapeutic or diagnostic agents. Improved ability to reduce sympathetic nerve activity in the adventitia and perivascular tissues around arteries and veins in the body. Modulation of the local tissue environment around an artery to enable more effective denervation with or without a therapeutic agent. Modulation may include adjustment of the pH of the tissue.
A composition comprising a guanidine with pH>8.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method for modulating local tissue physiology comprising the delivery of preparation comprising a liquid, gel, or semisolid into the tissue, wherein the preparation buffers the local tissue physiology by raising or lowering the pH of the local tissue.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of creating renal denervation comprising the localized delivery of an acid or base with sufficiently low or high pH to create localized nerve damage or destruction.
A method of creating renal denervation comprising the localized delivery of a non-isotonic or non-isoosmolar solution that creates neuronal destruction while sparing other local tissues.
A method comprising the delivery of a preparation of guanethidine monosulfate at pH>8 or guanethidine hemisulfate at pH>8 into the renal artery adventitia and perivascular tissues which is effective in treating hypertension, in treating heart failure, in treating insulin resistance, in treating systemic inflammation, or in treating sleep apnea.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of creating renal denervation comprising the localized delivery of a first toxin entering cells through sodium channels, wherein such first toxin comprises one or more of:
A method of creating renal denervation comprising the localized delivery of an agent,
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method for enhancing the uptake of therapeutic agents into tissue comprising
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.